These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12625122)

  • 21. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS; Kozuka Y; Kaneko K
    Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage display screening for peptides that inhibit polyglutamine aggregation.
    Kenan DJ; Strittmatter WJ; Burke JR
    Methods Enzymol; 2006; 413():253-73. PubMed ID: 17046401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics.
    Wan J; Khanna R; Sandusky M; Papazian DM; Jen JC; Baloh RW
    Neurology; 2005 Jun; 64(12):2090-7. PubMed ID: 15985579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways.
    Gunawardena S; Goldstein LS
    Arch Neurol; 2005 Jan; 62(1):46-51. PubMed ID: 15642849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of mitochondria in inherited neurodegenerative diseases.
    Kwong JQ; Beal MF; Manfredi G
    J Neurochem; 2006 Jun; 97(6):1659-75. PubMed ID: 16805775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding proteins for mRNA localization and local translation, and their dysfunction in genetic neurological disease.
    Bassell GJ; Kelic S
    Curr Opin Neurobiol; 2004 Oct; 14(5):574-81. PubMed ID: 15464890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misfolding of the prion protein: linking biophysical and biological approaches.
    Noinville S; Chich JF; Rezaei H
    Vet Res; 2008; 39(4):48. PubMed ID: 18533092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological chaperone action on G-protein-coupled receptors.
    Bernier V; Bichet DG; Bouvier M
    Curr Opin Pharmacol; 2004 Oct; 4(5):528-33. PubMed ID: 15351360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and molecular overlap between myopathies and inherited connective tissue diseases.
    Voermans NC; Bönnemann CG; Huijing PA; Hamel BC; van Kuppevelt TH; de Haan A; Schalkwijk J; van Engelen BG; Jenniskens GJ
    Neuromuscul Disord; 2008 Nov; 18(11):843-56. PubMed ID: 18818079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
    Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
    Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T; Lipton SA
    Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular stress and protein misfolding during aging.
    Basaiawmoit RV; Rattan SI
    Methods Mol Biol; 2010; 648():107-17. PubMed ID: 20700708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel therapeutic strategies for the treatment of protein-misfolding diseases.
    Rochet JC
    Expert Rev Mol Med; 2007 Jun; 9(17):1-34. PubMed ID: 17597554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of yeast as a model system to investigate protein conformational diseases.
    Coughlan CM; Brodsky JL
    Mol Biotechnol; 2005 Jun; 30(2):171-80. PubMed ID: 15920289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein misfolding and human disease.
    Gregersen N; Bross P; Vang S; Christensen JH
    Annu Rev Genomics Hum Genet; 2006; 7():103-24. PubMed ID: 16722804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid and the central nervous system: the neurobiology, genetics and immunocytochemistry of a process important in neurodegenerative diseases and stroke.
    Vinters HV
    Monogr Pathol; 1990; (32):55-85. PubMed ID: 2192280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.